Kevin Laliberte
-
- Heart Failure Treatment and Management 11
- Cardiovascular Issues in Pregnancy 5
- Cardiac Arrhythmias and Treatments 2
-
- Pulmonary Hypertension Research and Treatments 21
- Genetics top 5%
- Vascular Anomalies and Treatments 3
- Hepatology top 5%
- Liver Disease and Transplantation 5
-
- Organic and Inorganic Chemical Reactions 3
-
- Phosphodiesterase function and regulation 2
- Co-authors
- Carl ArnesonVictor F. TapsonRoblee P. AllenZhi‐Cheng JingLewis J. RubinMichael S. WadeRoger JeffsThomas L. Hunt
- Partner nations
- United StatesAustraliaChina
In The Last Decade
Kevin Laliberte
26 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 57
- Cardiology and Cardiovascular Medicine 869
- Pulmonary and Respiratory Medicine 1.1k
- Genetics 235
- Hepatology 124
- Surgery 141
Countries citing papers authored by Kevin Laliberte
This map shows the geographic impact of Kevin Laliberte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Laliberte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Laliberte more than expected).
Fields of papers citing papers by Kevin Laliberte
This network shows the impact of papers produced by Kevin Laliberte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Laliberte. The network helps show where Kevin Laliberte may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kevin Laliberte, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 51 | |
| 2 | 2016 | 47 | |
| 3 | 2014 | 8 | |
| 4 | 2013 | 242 | |
| 5 | 2013 | 27 | |
| 6 | 2013 | 12 | |
| 7 | 2013 | 10 | |
| 8 | 2013 | 226 | |
| 9 | 2013 | 9 | |
| 10 | 2012 | 10 | |
| 11 | 2012 | 294 | |
| 12 | 2012 | 4 | |
| 13 | 2010 | 1 | |
| 14 | 2010 | 21 | |
| 15 | 2010 | 8 | |
| 16 | 2009 | 7 | |
| 17 | 2009 | 6 | |
| 18 | 2006 | 16 | |
| 19 | 2005 | 30 | |
| 20 | 2004 | 152 |
About Kevin Laliberte
Kevin Laliberte is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Hepatology, having authored 26 papers that have together received 1.2k indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (21 papers), Heart Failure Treatment and Management (11 papers), Liver Disease and Transplantation (5 papers), Cardiovascular Issues in Pregnancy (5 papers), Vascular Anomalies and Treatments (3 papers), Organic and Inorganic Chemical Reactions (3 papers), Cardiac Arrhythmias and Treatments (2 papers) and Phosphodiesterase function and regulation (2 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (869 citations), Pulmonary and Respiratory Medicine (1.1k citations) and Genetics (235 citations). Kevin Laliberte has collaborated with scholars based in United States, Australia and China. Frequent co-authors include Carl Arneson, Victor F. Tapson, Roblee P. Allen, Zhi‐Cheng Jing, Lewis J. Rubin, Michael S. Wade, Roger Jeffs, Thomas L. Hunt, R. James White and Fernando Torres. Their work appears in journals such as Circulation, CHEST Journal and Clinical Pharmacokinetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.